Patents by Inventor Kimihiko Matsuzawa

Kimihiko Matsuzawa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5403716
    Abstract: The present invention provides an improved buffer solution for conducting an immunological method for measuring apoprotein of human tissue factor, and a kit therefor.
    Type: Grant
    Filed: September 3, 1992
    Date of Patent: April 4, 1995
    Assignee: Teijin Limited
    Inventors: Kimihiko Matsuzawa, Ryoichi Hasegawa
  • Patent number: 5374533
    Abstract: A method for determining chondrocalcin through an immunoassay using an enzyme(s)-labeled mammalian chondrocalcin or enzyme(s)-labeled anti-chondrocalcin antibody which is characterized by that mammalian body fluid is used as a specimen and immunoreaction in a solution is utilized to determine the chondrocalcin of the mammalian, reagents and a kit therefor.This determination can be utilized for diagnosis or the like for cartilage-relating diseases in mammals.
    Type: Grant
    Filed: April 23, 1993
    Date of Patent: December 20, 1994
    Assignee: Tetjin Limited
    Inventors: Kimihiko Matsuzawa, Kazuhiko Itou, Hitomi Honda, Ryoichi Hasegwwa, Naomi Okamoto, Kenji Hosoda, Masayuki Shinmei, Shigeo Matsuyama
  • Patent number: 4780205
    Abstract: A permselective hollow fiber membrane which is a hollow fiber membrane, made from a wet spinnable organic high polymer, having a dense skin layer of gelated structure made to a thickness of 1.mu. or less on at least one surface of the membrane and the rest being made up into a porous layer, a process for the preparation thereof, a method and an apparatus of plasma components separation in which said hollow fiber membrane is used.
    Type: Grant
    Filed: June 30, 1986
    Date of Patent: October 25, 1988
    Assignee: Teijin Limited
    Inventors: Eiichi Murakami, Kimihiko Matsuzawa, Eiji Masunaga
  • Patent number: 4059571
    Abstract: Novel immunoglobulin derivatives which are characterized in that in which the interchain disulfide bonds of immunoglobulin are predominantly cleaved, on the average 3 to 5 of the interchain disulfide bonds or the inter- and intra-chain disulfide bonds being cleaved, and so produced sulfur atoms (S-) are S-sulfonated (--S-SO.sub.3). The above immunoglobulin derivatives are prepared by reacting native immunoglobulin withA. a compound capable of forming tetrathionate ion, andB. a compound capable of forming in water, sulfite ion whereby cleaving on the average 3 to 5 inter-chain disulfide bonds, or inter- and intra-chain disulfide bonds, of the native immunoglobulin, and S-sulfonating (S-SO.sub.3) the so formed sulfur atoms. This invention also provides a water-soluble composition for injection containing said immunoglobulin derivative having the titre of anti-diphtheria of at least 1.0 I.U./ml at its concentration of 10.
    Type: Grant
    Filed: March 4, 1975
    Date of Patent: November 22, 1977
    Assignee: Teijin Limited
    Inventors: Katsuhiko Tomibe, Yasuhiko Masuho, Kimihiko Matsuzawa, Sachio Ishimoto, Kazuo Satake, Tsuneo Watanabe